Similar articles

• [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].

  Loubatières A, Ribes G, Mariani MM, Alric R. Loubatières A, et al. Acta Diabetol Lat. 1973 Mar-Apr;10(2):261-82. Acta Diabetol Lat. 1973. PMID: 4200420 Italian. No abstract available.
• [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].

  Beyer J, Cordes U, Sell G, Schöffling K. Beyer J, et al. Arzneimittelforschung. 1972 Dec;22:Suppl 12A:2176. Arzneimittelforschung. 1972. PMID: 4198965 German. No abstract available.
• Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics.

  Moncada Lorenzo E, Garcia RV, Barberia Layana JJ, Morant Ciscard JA, Calleja Canelas A. Moncada Lorenzo E, et al. Curr Ther Res Clin Exp. 1977 Jan;21(1):50-7. Curr Ther Res Clin Exp. 1977. PMID: 401712 Clinical Trial. No abstract available.
• Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?

  Marble A. Marble A. Drugs. 1971;1(2):109-15. doi: 10.2165/00003495-197101020-00001. Drugs. 1971. PMID: 4999930 Review. No abstract available.
• [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].

  Tattersall RB. Tattersall RB. Journ Annu Diabetol Hotel Dieu. 1984:183-91. Journ Annu Diabetol Hotel Dieu. 1984. PMID: 6443219 Review. French. No abstract available.